Agitation in head injury. I. Definition and treatment with anxiolytic neuroleptic and antiepileptic drugs;Agitacion en el traumatismo craneoencefadico. I. Definicion y tratamiento con neurolepticos, ansioliticos y antiepilepticos

Revista de Neurologia

Volumn 30, Issue 9, 2000, Pages 850-854

  Bascunana H ^a,b   Villarreal, I ^a   Alfonso, S ^a   Bernabeu, M ^a   Terre R ^a  

^a University Institute affiliated with the Autonomous University of Barcelona   (Spain)

^b Institut Guttmann   (Spain)

Author keywords

Agitation; Antiepileptic; Antipsychotic; Anxiolytic; Benzodiazepines; Head injury; Neuroleptic; Treatment

Indexed keywords

ANTICONVULSIVE AGENT; ANXIOLYTIC AGENT; NEUROLEPTIC AGENT;

AGITATION; ANXIETY NEUROSIS; ARTICLE; DRUG EFFICACY; HEAD INJURY; HUMAN; TREATMENT INDICATION; TREATMENT OUTCOME; BRAIN INJURY; EPILEPSY; RESTLESSNESS; REVIEW;

ANTI-ANXIETY AGENTS; ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; BRAIN INJURIES; EPILEPSY; HUMANS; PSYCHOMOTOR AGITATION;

EID: 0034185585     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3009.99434     Document Type: Article

References (55)

1. Levin HS, Grafman J, Eisenberg HM. Neurobehavioral recovery from head injury. New York: Oxford University Press; 1987.
2. Wood RL. Neurobehavioral sequelae of traumatic brain injury. New York: Taylor & Francis; 1990.
3. Reyes RL, Bhattacharyya AK, Heler D. Traumatic head injury: restlessness and agitation as prognosticators of physical and phychologic improvements in patients. Arch Phys Med Rehabil 1981; 62: 20-3.
4. Sandel ME, Mysiw WJ. The agitated brain injured patient. Part I. Definitions, differential diagnosis and assessment. Arch Phys Med Rehabil 1996; 77: 617-23.
5. Brooke MM, Questad KA, Patterson DR, Bashak KJ. Agitation and restlessness after closed head injury: a prospective study of 100 consecutive admissions. Arch Phys Med Rehabil 1992; 73: 320-3.
6. Hagen C, Malkmus D, Durham P. Levels of cognitive functioning. In Downey CA, ed. Rehabilitation of the head injured adult: comprehensive physical management. Los Angeles: Professional Staff Association of Rancho Los Amigos Hospital; 1979.
7. Corrigan JD, Mysiw WJ. Agitation following traumatic head injury: equivocal evidence for a discreet stage of cognitive recovery. Arch Phys Med Rehabil 1988; 69: 487-92.
8. Mysiw WJ, Jackson RD, Corrigan JD. Amitriptyline for post-traumatic agitation. Am J Phys Med Rehabil 1988; 67: 29-33.
9. Corrigan JD. Development of a scale for assessment of agitation following traumatic brain injury. J Clin Exp Neuropsychol 1989; 11: 261-77.
10. Diagnostic and statistical manual of mental disorders. 4 ed. Washington DC: American Psychiatric Association; 1994.
11. Kaplan HI, Sadock BJ. Pocket handbook of psychiatric drug treatment. Baltimore: Williams & Wilkins; 1993.
12. Safferman AZ, Kano JM, Aronowitz JS, Gordon MF, Pollack S, Lieberman JA. The use of clozapine in neurologic disorders. J Clin Psychiatry 1994; 55 (Suppl B): S98-101.
13. Czobor P, Volvavka J, Meibach RC. The effect of risperidone on hostility in schizophrenia. J Clin Psychopharmacol 1995; 15: 243-6.
14. Raho N, Jellinek HM, Woolston DC. Agitation in closed head injury: haloperidol effects on rehabilitation outcome. Arch Phys Med Rehabil 1985; 66: 30-4.
15. Raskind M. Geriatric psychopharmacology: management of late-life depression and the noncognitive behavioral disturbances of Alzheimer's disease. Psychiatr Clin North Am 1993; 4: 815-27.
16. Fava M. Psychopharmacologic treatment of pathologic aggression. Psychiatr Clin North Am 1997; 20: 427-51.
17. Klawans HL, Goetz CG, Tanner CM. Textbook of clinical neuropharmacology and therapeutics. New York: Raven Press; 1992.
18. Zimnitzky BM, DeMaso DR, Steingard RJ. Use of risperidone in psychosis disorder following ischemic brain damage. J Child Adolesc Psychopharmacol 1996; 6: 75-8.
19. Horn LJ, Zasler ND. Medical rehabilitation of traumatic brain injury. Saint Louis: Mosby; 1996.
20. Clinton JE, Sterner S, Stelmachers Z, Ruiz E. Haloperidol for sedation of disruptive emergency patients. Ann Emerg Med 1987; 16: 319-22.
21. Feeney DM, González A, Law WA. Amphetamine, haloperidol and experience interact to affect rate of recovery after motor cortex injury. Science 1982; 217: 855.
22. Feeney DM, Sutton RL. Pharmacotherapy for recovery of function after brain injury. Crit Rev Neurobiol 1987; 3: 135.
23. Goldstein LB. Basic and clinical studies of pharmacologic effects on recovery from brain injury. J Neural Transplant Plast 1993; 4: 175-92.
24. Meert TF, de Haes P, Jansse PAJ. Risperidone, a potent and complete LSD-antagonist in drug discrimination by rats. Psychopharmacology 1989; 97: 206-12.
25. Owens DGC. Extrapyramidal side effects and tolerability of risperidone: a review. J Clin Psychiatry 1994; 55: 29-34.
26. Mandoki M. Risperidone treatment of children and adolescents: increased risk of extrapyramidal side effects? J Child Adolesc Psychopharmacol 1995; 5: 49-67.
27. Rao N, Jellinek HM, Woolston DC. Haloperidol effects on rehabilitation outcome. Arch Phys Med Rehabil 1985; 66: 30-4.
28. Lazarus A. Neuroleptic malignant syndrome and preexisting brain damage. J Neuropsychiatry 1992; 4: 185-7.
29. Shalev A, Hermesh H, Munitz H. Mortality from neuroleptic malignant syndrome. J Clin Psychiatry 1989; 50: 18-25.
30. Sandel EM, Olive DA, Rader MA. Chlorpromazine-induced psychosis after brain injury. Brain Inj 1993; 7: 77-83.
31. Eames P, Wood R. Rehabilitation after severe brain injury: a special-unit approach to behavior disorders. Intern Rehabil Med 1985; 130-3.
32. Theodore WH. Complex partial seizures: clinical characteristics and differential diagnosis. Neurology 1983; 33: 1115-21.
33. Mysiw WH, Sandel ME. The agitated brain injury patient. Part 2. Pathophysiology and treatment. Arch Phys Med Rehabil 1997; 78: 213-20.
34. Wiercisiewski DR, McDeavitt JT. Drugs for management of acute and chronic behavioral disorders. Phys Med Rehabil Clin North Am 1997; 8: 763-80.
35. Neppe WM. Carbamazepine as adjunctive treatment in nonepileptic chronic inpatients with EEG temporal lobe abnormalities. J Clin Psychiatry 1983; 44: 326-31.
36. Mattes JA, Rosenberg J. Carbamazepine vs propranolol in patients with uncontrolled rage outbursts: a random assignment study. Psychopharmacol Bull 1984; 20: 98-100.
37. Trimble MR. Carbamazepine and mood: evidence from patients with seizure disorders. J Clin Psychiatry 1988; 49 (Suppl): S7-12.
38. Cloyd JC, Lackner TE, Leppik IE. Antiepileptics in the elderly: pharmacoepidemiology, pharmacokinetics. Arch Fam Med 1994; 3: 589-98.
39. Pourcher E, Filteau MJ, Boochard RH, Baruch P. Efficacy of the combination of buspirone and carbamazepine in early post-traumatic delirium. Am J Psychiatry 1994; 151: 150-1.
40. Pope HR Jr, McElroy SL, Satlin A. Head injury, bipolar disorder, and response to valproate. Compr Psychiatry 1988; 29: 34-8.
41. Van Valkenburg C, Kluznik JC, Merrill R. New uses of anticonvulsant drugs in psychosis. Drugs 1992; 44: 326-35.
42. Lott AD, McElroy SL, Keys MA. Valproate in the treatment of behavioral agitation in elderly patients with dementia. J Neuropsychiatry Clin Neurosci 1995; 7: 314-9.
43. Childers MK, Holland D. Psychomotor agitation following gabapentin use in brain injury. Brain Inj 1997; 7: 537-40.
44. Rodgers RJ, Waters AJ. Benzodiazepines and their antagonists: a pharmacoethological analysis with particular reference to effects on 'aggression'. Neurosci Biobehav Rev 1985; 9: 21-35.
45. Strahan A, Rosenthal J, Kaswan M. Three case reports of acute paroxysmal excitement associated with alprazolam treatment. Am J Psychiatry 1985; 142: 859-61.
46. Edwards R, Stephenson U, Flewett T. Clonazepam in acute mania: a double blind trial. Aust N Z J Psychiatry 1991; 25: 238-42.
47. Fish DN. Treatment of delirium in the critically ill patient. Clin Pharm 1991; 10: 456-66.
48. Duffy JD, Malloy PF. Efficacy of buspirone in the treatment of post-traumatic stress disorder: an open trial. Ann Clin Psychiatry 1994; 6: 33-7.
49. Joffe RT, Schuller DR. An open study of buspirone augmentation of serotonin reuptake inhibitors in refractory depression. J Clin Psychiatry 1993; 54: 269-71.
50. Ricketts RW, Goza AR, Ellis CR, Singh YN, Chambers S, Sing NN. Clinical effects of buspirone on intractable self-injury in adults with mental retardation. J Am Acad Child Adolesc Psychiatry 1994; 33: 270-6.
51. Ratey JJ, Leveroni CL, Miller AC, Komry V, Gaffar K. Low-dose buspirone to treat agitation and maladaptive behavior in brain-injuried patients: two case reports. J Clin Psychopharmacol 1992; 12: 362-4.
52. Barbee JG, Black FW, Todorov AA. Differential effects of alprazolam and buspirone upon acquisition, retention, and retrieval processes in memory. J Neuropsychiatry Clin Neurosci 1992; 4: 308-14.
53. Stanislav S. Buspirone's efficacy in organic induced aggression. Psychophamacology 1994; 2: 126-30.
54. Gualtierri T. Buspirone for the behavioral problems of patients with organic brain disorders. J Clin Psychopharmacol 1991; 11: 280.
55. Fugate LP, Spacek LA, Kresty LA, Levy CE, Johnson JC, Mysiw WJ. Measurement and treatment of agitation following traumatic brain injury. II. A survey of the Brain Injury Special Interest Group of the American Academy of Physical Medicine and Rehabilitation. Arch Phys Med Rehabil 1997; 78: 924-9.